Publicaciones (25) Publicaciones de Francisco Román González Pachecho

2012

  1. Murine recombinant angiotensin-converting enzyme 2: Effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2

    Hypertension, Vol. 60, Núm. 3, pp. 730-740

2010

  1. Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: Prevention of angiotensin II-dependent hypertension

    Hypertension, Vol. 55, Núm. 1, pp. 90-98

2009

  1. Alkalinization potentiates vascular calcium deposition in an uremic milieu

    Journal of Nephrology, Vol. 22, Núm. 5, pp. 647-653

  2. Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity

    Kidney International, Vol. 75, Núm. 2, pp. 227-234

2008

  1. Aldosterone increases vascular calcification in "in vitro" studies

    Nefrología

  2. Angiotensin-converting enzyme 2: Possible role in hypertension and kidney disease

    Current Hypertension Reports, Vol. 10, Núm. 1, pp. 70-77

  3. Induction of hypoxia-inducible factor 1α gene expression by vascular endothelial growth factor

    Journal of Biological Chemistry, Vol. 283, Núm. 17, pp. 11435-11444

2007

  1. Mechanisms of endothelial cell protection by blockade of the JAK2 pathway

    American Journal of Physiology - Cell Physiology, Vol. 292, Núm. 3

2006

  1. Mechanisms of endothelial response to oxidative aggression: Protective role of autologous VEGF and induction of VEGFR2 by H2O2

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 291, Núm. 3

  2. Respuesta a la hipoxia. Un mecanismo sistemico basado en el control de la expresion genica

    Medicina, Vol. 66, Núm. 2, pp. 155-164

2004

  1. Cyclosporin A toxicity, and more: Vascular endothelial growth factor (VEGF) steps forward

    Nephrology Dialysis Transplantation

  2. Papel del factor de crecimiento endotelial vascular (VEGF) en la protección de las células endoteliales

    Nefrología, Vol. 24, Núm. SUPPL.1, pp. 6-7

  3. Tumor-induced endothelial cell activation: Role of vascular endothelial growth factor

    American Journal of Physiology - Cell Physiology, Vol. 286, Núm. 5 55-5

2003

  1. Effect of AT 1 receptor blockade on hepatic redox status in SHR: Possible relevance for endothelial function?

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 285, Núm. 3 54-3

  2. Papel del VEGF en la respuesta celular a la agresión

    Nefrologia, Vol. 23, Núm. SUPPL.3, pp. 54-57

2002

  1. Cyclophilin-mediated pathways in the effect of cyclosporin A on endothelial cells: Role of vascular endothelial growth factor

    Circulation Research, Vol. 91, Núm. 3, pp. 202-209

  2. Mechanism of vascular smooth muscle cells activation by hydrogen peroxide: Role of phospholipse C gamma

    Nephrology Dialysis Transplantation, Vol. 17, Núm. 3, pp. 392-398

  3. Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity

    Transplantation, Vol. 74, Núm. 11, pp. 1618-1624

2001

  1. Structural changes and vascular calcifications in uremia

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21, Núm. 6, pp. 538-547

2000

  1. Role of vascular endothelial growth factor (VEGF) in endothelial cell protection against cytotoxic agents

    Life Sciences, Vol. 67, Núm. 9, pp. 1003-1013